Who We AreWho We Are

Business Partners to CONVINCE is a new multi-sector effort to empower a “vaccine-literate” public, based on trust in science and aligned commitment to future COVID-19 vaccines and other novel countermeasures. The initiative is the private sector arm of the global, multi-sector CONVINCE (COVID-19 New Vaccine Information, Communication, and Engagement) initiative that advances vaccine literacy and promotes vaccine acceptance.

Our Mission: Business Partners to CONVINCE will mobilize the business community to engage employers and employees to accept COVID-19 vaccines.

The private sector can play a pivotal role in addressing vaccine hesitancy with its extensive reach and the high level of trust imbued in employers by their employees. Many companies have already stepped up to make their workplaces safer, provided guidance on how to keep themselves and their families safer and provided up-to-date information from health professionals to follow the science.

One area they have not yet addressed is on helping to engage their employees on the importance of vaccines, and specifically a COVID-19 vaccine. Business Partners to CONVINCE is building a coalition of employers and other stakeholders from the private sector to fill that gap and work together to develop fact-based messaging and tool kits that will encourage uptake of a COVID-19 vaccine by their employees. The breakdown of trust in vaccines cannot be solved overnight. Join The Global COVID-19 Workplace Challenge.

Join the Challenge!

The United States Council for International Business (USCIB), The USCIB Foundation, and Business Partners for Sustainable Development (BPSD) have launched Business Partners to CONVINCE, a global communication and education initiative to promote COVID-19 vaccine acceptance among private sector employers and employees.

The new partnership will play an integral role in a broader, global CONVINCE (COVID-19 New Vaccine Information, Communication, and Engagement) campaign to advance vaccine literacy and help ensure a strong and swift recovery from the COVID-19 pandemic through widespread acceptance of safe, effective and accessible vaccines.